Expertise in
6
conditions
Expertise in
6
conditions
TriStar Medical Group Children's Specialists
330 23rd Ave N Ste 100, 
Nashville, TN 

Overview

Meghann Mcmanus is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee.

Dr. Mcmanus is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Beta Thalassemia, Niemann-Pick Disease, Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy, Bone Marrow Aspiration, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 20 clinical trials. Dr. Mcmanus is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in UT

Hospital Affiliations

Tristar Centennial Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

TriStar Medical Group Children's Specialists
330 23rd Ave N Ste 100, Nashville, TN 37203

Additional Areas of Focus

Dr. Mcmanus has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
View 8 Less Clinical Trials
Similar Doctors
Expertise in
22
conditions
Hematology | Oncology
Expertise in
22
conditions
Hematology | Oncology
Referral may be required

TriStar Medical Group Children's Specialists

330 23rd Ave N Ste 100, 
Nashville, TN 
 (1.0 miles away)
Languages Spoken:
English
Accepting New Patients

Haydar Frangoul is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Frangoul is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Frangoul is currently accepting new patients.

Expertise in
5
conditions
Hematology | Oncology
Expertise in
5
conditions
Hematology | Oncology
Referral may be required

Vanderbilt Children's Hematology-Oncology

2200 Childrens Way # 6, 
Nashville, TN 
 (1.5 miles away)
Languages Spoken:
English
Offers Telehealth

Michael Debaun is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Debaun is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Expertise in
6
conditions
Hematology | Oncology
Expertise in
6
conditions
Hematology | Oncology
Referral may be required

Office

2200 Childrens Way Fl 6, 
Nashville, TN 
 (1.5 miles away)
Languages Spoken:
English
Offers Telehealth

Carrie Kitko is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Kitko is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Lymphoblastic Leukemia (ALL), Febrile Neutropenia, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Meghann Mcmanus

Is Dr. Meghann Mcmanus a top-rated expert for Beta Thalassemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghann Mcmanus is classified as an Advanced expert for Beta Thalassemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Meghann Mcmanus specialize in?

While Dr. Meghann Mcmanus is a Hematology, they have specific expertise in Beta Thalassemia, Niemann-Pick Disease, and Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Meghann Mcmanus participate in research or clinical trials?

Yes. Dr. Meghann Mcmanus has published 10 articles and abstracts on conditions like Beta Thalassemia. You can view a list of Dr. Meghann Mcmanus's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Meghann Mcmanus accept my insurance?

Dr. Meghann Mcmanus accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mcmanus's expertise for a condition
ConditionClose
      View All 38 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile